Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Anhydramnios Fetal Therapy (RAFT) Trial

NCT03101891 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03101891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03101891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Anhydramnios Fetal Therapy (RAFT) Trial
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Completed
Start date
December 21, 2018
Completion date
February 27, 2026
Enrollment
55 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

anhydramnios, fetal renal anomaly, lower urinary tract obstructive syndrome, lung hypoplasia, multicystic dysplastic kidney, multicystic renal dysplasia, bilateral, potter syndrome